CompanyTrack
N

NEWCELLS BIOTECH LIMITED

Active Newcastle Upon Tyne

Research and experimental development on biotechnology

47 employees Website
Life sciences and medical technology Research and experimental development on biotechnology
N

NEWCELLS BIOTECH LIMITED

Research and experimental development on biotechnology

Founded 15 Jan 2015 Active Newcastle Upon Tyne, United Kingdom 47 employees newcellsbiotech.co.uk
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 30 Jun 2025
Confirmation Statement Submitted 22 Jan 2025
Net assets £73.31K £3.56M 2025 year on year
Total assets £0.00 £4.21M 2025 year on year
Total Liabilities £-140.87K £1.14M 2025 year on year
Charges 2
1 outstanding 1 satisfied

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Time Central 32 Gallowgate Newcastle Upon Tyne Tyne And Wear NE1 4BF United Kingdom

Office (Newcastle upon Tyne)

Newcells Biotech, The Biosphere, Drayman Helix, South St, Newcastle upon Tyne NE4 5BX

Credit Report

Discover NEWCELLS BIOTECH LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2015–2025)

Cash in Bank

£612.06k

Decreased by £1.52M (-71%)

Net Assets

£73.31k

Decreased by £3.56M (-98%)

Total Liabilities

-£140.87k

Decreased by £1.14M (-114%)

Turnover

N/A

Employees

47

Increased by 3 (+7%)

Debt Ratio

N/A

Decreased by 24 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

6 Allotments 2,326,595 Shares £5.84m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 Dec 202343,515£126k£2.886
13 Dec 2023389,849£1.12m£2.886
13 Dec 2023381,185£1.10m£2.886
13 Dec 2023536,533£1.24m£2.309
13 Dec 2023873,573£2.02m£2.309

Officers

Officers

7 active 5 resigned
Status
Lyle ArmstrongDirectorBritishUnited Kingdom6015 Jan 2015Active
Mark Carnegie-brownDirectorBritishUnited Kingdom6526 Nov 2024Active
Mercia Fund Management (nominees) LimitedCorporate-directorUnited KingdomUnknown17 Sept 2025Active
Michael John NicholdsDirectorBritishEngland6515 Jan 2015Active
Muckle Secretary LimitedCorporate-secretaryUnited KingdomUnknown24 Feb 2017Active
Simon Andrew BerryDirectorBritishUnited Kingdom535 Mar 2024Active
Terence William PizzieDirectorBritishUnited Kingdom651 Sept 2023Active

Shareholders

Shareholders (34)

The North East (erdf) Venture Capital Limited Partnership (acting By Enterprise Ventures (general Partner Ne Venture) Limited
7.8%
573,73725 Jan 2024
The North East Accelerator Limited Partnership Acting By Its General Partner North East Accelerator General Partner Limited
3.7%
272,00025 Jan 2024
The North East (erdf) Venture Capital Limited Partnership (acting By Enterprise Ventures (general Partner Ne Venture) Limited
2.8%
206,61225 Jan 2024

Persons with Significant Control

Persons with Significant Control (3)

3 Active 2 Ceased

North East Accelerator General Partner Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Significant Influence Or Control

Mercia Fund Management Limited

United Kingdom

Active
Notified 20 Jun 2018
Nature of Control
  • Significant Influence Or Control

Northstar Ventures Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Significant Influence Or Control

Professor Lyle Armstrong

Ceased 20 Jun 2018

Ceased

Nvmequity Llp

Ceased 20 Jun 2018

Ceased

Group Structure

Group Structure

NORTHSTAR VENTURES LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
NORTH EAST ACCELERATOR GENERAL PARTNER LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
MERCIA FUND MANAGEMENT LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
NORTHSTAR VENTURES HOLDINGS LIMITED united kingdom shares 50 to 75 percent, voting rights 50 to 75 percent
THE NORTHSTAR FOUNDATION united kingdom
NEWCELLS BIOTECH LIMITED Current Company

Charges

Charges

1 outstanding 1 satisfied

Documents

Company Filings

DateCategoryDescriptionDocument
30 Sept 2025OfficersAppointment of Mercia Fund Management (Nominees) Limited as director on 2025-09-17View(2 pages)
30 Sept 2025OfficersTermination of Victoria Jane Wiesener as director on 2025-09-17View(1 page)
4 Jul 2025ResolutionResolutionsView(3 pages)
4 Jul 2025IncorporationMemorandum ArticlesView(79 pages)
30 Jun 2025AccountsAnnual accounts made up to 2025-01-31View(16 pages)
30 Sept 2025 Officers

Appointment of Mercia Fund Management (Nominees) Limited as director on 2025-09-17

30 Sept 2025 Officers

Termination of Victoria Jane Wiesener as director on 2025-09-17

4 Jul 2025 Resolution

Resolutions

4 Jul 2025 Incorporation

Memorandum Articles

30 Jun 2025 Accounts

Annual accounts made up to 2025-01-31

Recent Activity

Latest Activity

Appointment of Mercia Fund Management (Nominees) Limited as director on 2025-09-17

4 months ago on 30 Sept 2025

Termination of Victoria Jane Wiesener as director on 2025-09-17

4 months ago on 30 Sept 2025

Resolutions

7 months ago on 4 Jul 2025

Memorandum Articles

7 months ago on 4 Jul 2025

Annual accounts made up to 2025-01-31

7 months ago on 30 Jun 2025